# Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

> **NCT00888628** · PHASE1,PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 7 (actual)

## Conditions studied

- Diabetes Mellitus, Type I

## Interventions

- **BIOLOGICAL:** Purified Pancreatic Islets
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00888628
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2014-08
- **Final completion:** 2016-08
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2017-11-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888628, "Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00888628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*